Evidence map›Paper›PMID 32419471›Full record

ArticleEuropean heart journal. Acute cardiovascular care2021

Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Lars Nepper-Christensen, Jacob Lønborg, Dan Eik Høfsten, Golnaz Sadjadieh, Mikkel Malby Schoos, Frants Pedersen, Erik Jørgensen, Henning Kelbæk, Sune Haahr-Pedersen, Jens Flensted Lassen and 3 more

Abstract read
In one paragraph

Article in European heart journal. Acute cardiovascular care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lars Nepper-ChristensenDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Jacob LønborgDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Dan Eik HøfstenDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Golnaz SadjadiehDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Mikkel Malby SchoosDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Frants PedersenDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Erik JørgensenDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Henning KelbækDepartment of Cardiology, Zealand University Hospital, Denmark.
Sune Haahr-PedersenDepartment of Cardiology, Gentofte University Hospital, Denmark.
Jens Flensted LassenDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Lars KøberDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Lene HolmvangDepartment of Cardiology, Copenhagen University Hospital, Denmark.
Thomas EngstrømDepartment of Cardiology, Copenhagen University Hospital, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUp to 40% of patients with ST-segment elevation myocardial infarction (STEMI) present later than 12 hours after symptom onset. However, data on clinical outcomes in STEMI patients treated with primary percutaneous coronary intervention 12 or more hours after symptom onset are non-existent. We evaluated the association between primary percutaneous coronary intervention performed later than 12 hours after symptom onset and clinical outcomes in a large all-comer contemporary STEMI cohort.

methodsAll STEMI patients treated with primary percutaneous coronary intervention in eastern Denmark from November 2009 to November 2016 were included and stratified by timing of the percutaneous coronary intervention. The combined clinical endpoint of all-cause mortality and hospitalisation for heart failure was identified from nationwide Danish registries.

resultsWe included 6674 patients: 6108 (92%) were treated less than 12 hours and 566 (8%) were treated 12 or more hours after symptom onset. During a median follow-up period of 3.8 (interquartile range 2.3-5.6) years, 30-day, one-year and long-term cumulative rates of the combined endpoint were 11%, 17% and 25% in patients treated 12 or fewer hours and 21%, 29% and 37% in patients treated more than 12 hours (

conclusionsIncreasing duration from symptom onset to primary percutaneous coronary intervention was associated with an increased risk of an adverse clinical outcome in patients with STEMI, especially when the delay exceeded 12 hours.

Indexed as

clinical outcomelate reperfusionprimary percutaneous coronary interventionST-segment elevation myocardial infarction

Identifiers

PMID32419471
PMCPMC8248842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.